Pavmed Inc
(PAVM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 288 | 6,300 | 18,623 | 28,427 | 27,285 |
| Depreciation Amortization | 87 | 65 | 43 | 1,198 | 1,129 |
| Accounts receivable | 15 | 15 | 8 | 43 | 45 |
| Accounts payable and accrued liabilities | -315 | -268 | -286 | -59 | -249 |
| Other Working Capital | -77 | -259 | -328 | 512 | -563 |
| Other Operating Activity | -3,653 | -8,612 | -19,641 | -63,675 | -61,295 |
| Operating Cash Flow | $-3,655 | $-2,759 | $-1,581 | $-33,554 | $-33,648 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -14 | -6 | -55 | -51 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 350 | 350 |
| Other Investing Activity | 0 | 0 | 0 | -16,129 | -16,129 |
| Investing Cash Flow | $-17 | $-14 | $-6 | $-16,184 | $-16,180 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -531 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -531 |
| Common Stock Issued | 5,699 | 5,701 | 3,211 | 2,017 | 1,687 |
| Other Financing Activity | -109 | -109 | -109 | 29,798 | 29,798 |
| Financing Cash Flow | $5,590 | $5,592 | $3,102 | $31,284 | $30,954 |
| Beginning Cash Position | 1,185 | 1,185 | 1,185 | 19,639 | 19,639 |
| End Cash Position | 3,103 | 4,004 | 2,700 | 1,185 | 765 |
| Net Cash Flow | $1,918 | $2,819 | $1,515 | $-18,454 | $-18,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,655 | -2,759 | -1,581 | -33,554 | -33,648 |
| Capital Expenditure | -17 | -14 | -6 | -55 | -51 |
| Free Cash Flow | -3,672 | -2,773 | -1,587 | -33,609 | -33,699 |